The Community Youth Development Study: A Test of Communities That Care (CYDS III)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01088542|
Recruitment Status : Completed
First Posted : March 17, 2010
Last Update Posted : May 18, 2017
|Condition or disease||Intervention/treatment||Phase|
|Substance Abuse Juvenile Delinquency Sexual Behavior Criminal Behavior Violence Depression Anxiety Suicide Sexually Transmitted Infection Educational Attainment||Behavioral: Communities That Care||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||52323 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Long-term Effects of Communities That Care on Young Adults From Small Towns|
|Study Start Date :||October 2003|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
No Intervention: No intervention
Communities in the no intervention arm received no intervention from the project and continued to implement prevention services as usual.
Experimental: Communities That Care Intervention
Communities randomly assigned to the experimental condition received 5 years of training and technical assistance (from 2003 to 2008) to implement the Communities That Care (CTC) prevention system in their communities. They also received 5 years of funding to support a full-time community coordinator and 4 years of seed money to implement tested and effective prevention programs selected as a result of their CTC process.
Behavioral: Communities That Care
The Communities That Care (CTC) system provides communities training and ongoing technical assistance in a structured process for conducting prevention needs assessments using epidemiological data on levels of risk and protective factors for adolescent problem behaviors, selection of tested and effective preventive interventions shown to address community-prioritized factors, implementation of these interventions with fidelity, and evaluation of the community's progress toward its goals. The CTC system is designed to produce a plan for prevention services that is tailored to the needs of each community. CTC is installed in five phases through a manualized series of training events designed to build the capacity of communities to install and sustain the system over time.
- Targeted risk and protective factors, substance use, delinquency, violence [ Time Frame: Baseline through thirteen-year follow-up (age 23) ]Surveys of the panel starting in 5th grade (2004) and continuing in grades 6-10, grade 12, and at ages 19, 21, and 23 are used to assess the impact of the intervention on risk and protective factors targeted by communities, substance use, delinquency, and violence. Cross-sectional surveys of all youth in grades 6, 8, 10, and 12 in all participating communities, conducted every 2 years from 2002 through 2012, are also used to assess the impact of the intervention on these primary outcomes.
- CTC coalition functioning, prevention system transformation, evidence-based program (EBP) implementation [ Time Frame: Baseline through eight-year follow-up (age 18) ]Structured telephone interviews with key community leaders, CTC coalition members, and prevention services providers (Community Key Informant Survey, Coalition Board Interview, Community Resource Documentation Survey) conducted in 2001-02, 2004-05, 2007-08, 2009-10, and 2011-12 are used to assess intervention effects on CTC coalition functioning, prevention system transformation, and evidence-based prevention program implementation.
- Substance use disorder, depression and generalized anxiety disorder, sexual risk behavior [ Time Frame: Nine- through thirteen-year follow-up ]Secondary outcomes salient in late adolescence and young adulthood were added to the self-report longitudinal survey beginning at the nine-year follow-up (age 19).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01088542
|United States, Washington|
|University of Washington|
|Seattle, Washington, United States, 98115|
|Principal Investigator:||Sabrina Oesterle, Ph.D.||University of Washington|